Skip to main content

Table 1 Pre-vaccine and post-vaccine SLEDAI, laboratory values and prednisone doses of those who completed the study

From: Safety and immunogenicity of the quadrivalent HPV vaccine in female Systemic Lupus Erythematosus patients aged 12 to 26 years

Variable

n

Pre-Mean (SD)

Post- Mean (SD)

95% CI

p-value

SLEDAI

20

6.14 (3.7)

4.49 (2.8)

(−2.85, -0.44)

0.010

Anti-ds-DNA*

16

1.67 (0.28)

1.49 (0.25)

(−0.46, 0.09)

0.17

ESR mm/hr

17

40.9 (21.4)

41.2 (25.6)

(−6.7, 7.4)

0.91

CRP mg/L

15

4.48 (3.53)

3.30 (1.72)

(−2.88, 0.52)

0.16

C3 mg/dl

20

92.3 (29.9)

93.0 (26.0)

(−7.4, 8.7)

0.86

C4 mg/dl

20

18.2 (10.0)

20.1 (12.4)

(−1.8, 5.7)

0.30

Prednisone (mg) dose

16

12.6 (10.8)

7.4 (5.9)

(−8.5, -1.9)

0.005

  1. *Log10 transformed.